<DOC>
	<DOCNO>NCT02802644</DOCNO>
	<brief_summary>This study evaluate effect dipeptidyl-peptidase 4 inhibitor vascular heal biodegradable polymer base sirolimus elute stent implantation diabetic pateints .</brief_summary>
	<brief_title>The Effect DPP4 Inhibitor Vasclular Healing</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Dipeptidyl-Peptidase IV Inhibitors</mesh_term>
	<criteria>NonST segement elevation acute coronary syndrome Left main disease Known hypersensitivity contraindication follow medication : Heparin , aspirin , clopidogrel , sirolimus , siptagliptin statin Congestive heart failure ( patient LVEF &lt; 30 % cardiogenic shock ) Uncontrolled myocardial ischemia ( repeat chest pain dyspnea revascularization ) Uncontrolled ventricular arrhythmia History malignancy chemotherapy Serious hematologic disease ( e.g . CML , MDS ) Current infectious disease need antibiotic therapy Creatinine level &gt; 1.5 mg/dL dependence dialysis Other severe concurrent illness ( e.g . active infection , malignancy ) . Life expectancy less one year Pregnancy woman potential childbearing Type I DM Treatment insulin History pancreatitis Who read informed consent form ( e.g . illiteracy , foreigner )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>